Daily non-political popular news in brief.

Researchers train the immune system to deliver virus that destroys cancer in lab models

An international team of researchers led by Mayo Clinic have designed a technique that uses the body's own cells and a virus to destroy cancer cells that spread from primary tumors to other parts of the body through the lymphatic system.

Read more »

Keywords: researchers, train, immune, system, deliver, virus, destroys, cancer, lab, models, researcher, viru, destroy, model

« Previous | Next »

Similar news on "Researchers train the immune system to deliver virus that destroys cancer in lab models":

1. MIT model could predict cells' response to drugs
   07-30-2007 · EurekAlert!
   MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
   Similar news · Read more »
   
2. Second pathway behind HIV-associated immune system dysfunction identified
   09-30-2007 · EurekAlert!
   Researchers at the Partners AIDS Research Center at Massachusetts General Hospital may have discovered a second molecular 'switch' that turns off the immune system's response against HIV. Last year the same team identified a molecule that suppresses the activity of HIV-specific CD8 T cells that should destroy virus-infected cells. Now they describe how a regulatory protein called CTLA-4 inhibits the action of HIV-specific CD4 T cells that control the overall response against the virus.
   Similar news · Read more »
   
3. An AIDS-related virus reveals more ways to cause cancer, Penn researchers find
   10-08-2007 · EurekAlert!
   Researchers have shed new light on how Kaposi's Sarcoma-associated Herpes Virus subverts normal cell machinery to cause cancer. A KSHV protein called latency-associated nuclear antigen (LANA) helps the virus hide out from the immune system in infected cells. When LANA takes the place of other proteins that control cell growth, it can cause uncontrolled cell replication.
   Similar news · Read more »
   
4. Animal study identifies promising new target for brain tumor therapy
   05-08-2007 · EurekAlert!
   A drug that targets the body's immune cells may be effective in treating malignant brain tumors, according to a new study led by researchers from Duke's Preston Robert Tisch Brain Tumor Center. In animal models, the drug re-engaged the body's cancer-damaged immune system.
   Similar news · Read more »
   
5. Jefferson researchers boost immune 'killer cells,' increase antibody effectiveness against cancer
   04-18-2007 · EurekAlert!
   Researchers have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body. They have shown in laboratory studies that adding such cells to anti-cancer therapies involving monoclonal antibody drugs such as Herceptin, which targets the HER2/neu protein on breast cancer cells, is more effective in killing cancer cells, and perhaps someday may improve treatments.
   Similar news · Read more »
   
6. Immune compound blocks virus' ability to hijack antibodies
   12-12-2007 · EurekAlert!
   Researchers at Washington University School of Medicine in St. Louis have shown that a controversial phenomenon known as antibody-dependent enhancement of infection is suppressed by C1q, a blood-borne immune system compound. The link may give researchers the lead they need to begin untangling a snarl of evidence from decades of puzzling epidemiological and laboratory-based studies of ADE.
   Similar news · Read more »
   
7. Human antibodies that block human and animal SARS viruses identified
   07-02-2007 · EurekAlert!
   An international team of investigators has identified the first human antibodies that can neutralize different strains of virus responsible for outbreaks of severe acute respiratory syndrome (SARS). The researchers used a mouse model and in vitro assays (lab tests) to test the neutralizing activity of the antibodies.
   Similar news · Read more »
   
8. Antibody leads to repair of myelin sheath in lab study of multiple sclerosis and related disorders
   10-09-2007 · EurekAlert!
   Mayo Clinic researchers have found that a human antibody administered in a single low dose in laboratory mouse models can repair myelin, the insulating covering of nerves that when damaged can lead to multiple sclerosis and other disorders of the central nervous system.
   Similar news · Read more »
   
9. Vaccine improves event-free survival for leukemia patients
   12-09-2007 · EurekAlert!
   Patients whose immune system responded to a peptide vaccine for leukemia enjoyed a median remission that was more than three times longer than nonresponders, a team led by researchers at the University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
   Similar news · Read more »
   
10. New study may show how to forestall a fatal, virus-caused immune-system meltdown
    02-14-2007 · EurekAlert!
    Researchers at the University of Texas Medical Branch at Galveston believe they've found a way to spot the biochemical profile of an inappropriate immune response to viral infection -- an important step toward developing new therapies that may stop the fatal immune system meltdowns caused by such deadly pathogens as the Ebola, Marburg and Lassa fever viruses, as well as the virus strain responsible for the 1918 flu pandemic.
    Similar news · Read more »